Stella Matthaiou

Stella Matthaiou currently serves as the Head of Analytical Development at Elpen Pharmaceutical Co. Inc. since September 2019. Prior to this role, Stella held various positions at Genepharm SA from December 2004 to August 2019, including Manager of Analytical Development, RnD Group Leader, RnD Analyst, and CMC Officer. Stella's earlier experience includes a position as a Scientist at OAKA Doping Control Laboratory from March 2003 to September 2004, and a consultancy role in Doping Control Services for the Athens 2004 Olympic and Paralympic Games Organising Committee from February 2002 to February 2003.